ascendis pharma glp-1 receptor agonist Novo inks deal to develop long-acting GLP-1, other metabolic drugs Current Insights, Advantages and Challenges

This guide examines peer-reviewed research on EVOO and GLP-1 secretion, hydroxytyrosol and insulin sensitivity, oleocanthal and inflammation, and why these olive-specific compounds are distinct from other dietary polyphenols

Effectiveness and Impact Significant Weight Loss: Phase 2 studies showed up to roughly 20% average body weight loss at 52 weeks in participants with obesity

Using a global dataset and propensity matching, they found significantly lower mortality rates, major cardiovascular events (MACEs), and adverse kidney outcomes (MAKEs) among GLP-1 RA users compared to non-users

#GLP1 #DiabetesCare #ObesityManagement #PharmaIndustry #ClinicalResearch #DrugDevelopment #HealthcareInnovation #Endocrinology #Biotech #RegulatoryAffairs

The PatchAid Berberine Patch delivers a plant-based formula straight through your skin

The heatmap below illustrates how side effects differ across GLP-1 drugs, offering a snapshot of how people experience their GLP-1 medication in everyday life